Meningococcal vaccination: cui bono?
Szucs
Thomas D
TD
D003362:Cost-Benefit Analysis; D006801:Humans; D008585:Meningitis, Meningococcal / Q000191:economics* / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000191:economics* / Q000627:therapeutic use*
D022401:Meningococcal Vaccines